EPHA2 and osteosarcoma: Anti-EphA2 CAR T intravenously infused in osteosarcoma, and Ewing’s sarcoma-bearing mice significantly improved their survival and eradicated metastatic deposits in liver and lungs in an aggressive metastatic osteosarcoma murine model [37].